{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.175","meta":{"versionId":"6","lastUpdated":"2021-03-19T01:00:22.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.175","version":"20210319","name":"Immunotherapy Administration","status":"active","date":"2021-03-19T01:00:22-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","concept":[{"code":"180223008","display":"Intravenous immunotherapy (procedure)"},{"code":"180244008","display":"Intramuscular immunotherapy (procedure)"},{"code":"180256009","display":"Subcutaneous immunotherapy (procedure)"},{"code":"589631000119102","display":"Intravenous radioimmunotherapy using monoclonal antibodies (procedure)"},{"code":"60827006","display":"Lymphokine activated killer cell therapy (procedure)"},{"code":"64644003","display":"Immunotherapy for cancer (procedure)"},{"code":"72255009","display":"Interleukin-2 therapy (procedure)"},{"code":"76334006","display":"Immunotherapy (procedure)"},{"code":"84501003","display":"Cytokine therapy (procedure)"},{"code":"870387009","display":"Immune checkpoint inhibitor therapy (procedure)"}]}]}}